Clinical trial
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections…
NCT00034671 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00034671 |
|---|---|
| Title | PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) |
| Official title | Phase II Study of Safety, Tolerance, Efficacy, and Pharmacokinetics of Posaconazole (SCH 56592) for the Treatment of Invasive Fungal Infections in Immunocompromised Hosts |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mycoses |
| Intervention type | Drug |
| Interventions | Posaconazole oral suspension |
| Enrollment | 98 |
| Start date | Jan 1, 2001 |
| Primary completion | Nov 1, 2001 |
| Completion | Mar 1, 2002 |
| First posted | May 2, 2002 |
| Last update posted | Dec 31, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: